Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three and a Half Decades of Pediatric Heart Transplantation: Evolution of Surgical Practice and Outcomes at a High-Volume Centre.

Journal of cardiovascular development and disease·2026
Same author

SiC resistive X-ray beam monitor for intensity and position control of synchrotron light.

Journal of synchrotron radiation·2026
Same author

[Monocentric cohort analysis of anaesthesiological management of pregnant women with congenital heart disease].

Die Anaesthesiologie·2026
Same author

Adenosine Pathway Activation Defines Genetically Linked Immunosuppressive Subtypes in Solid Tumor Brain Metastases.

Cancers·2026
Same author

Interprofessional education in healthcare professions - implementation status and preferences from the perspective of teaching staff.

GMS journal for medical education·2026
Same author

Clinical Epidemiology of Cancer in People Living With HIV in Germany: Retrospective, Observational, Multicenter Federated Claims Data Analysis.

JMIR public health and surveillance·2026

Related Experiment Video

Updated: Jan 3, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.4K

UVC-Emitting LuPO4:Pr3+ Nanoparticles Decrease Radiation Resistance of Hypoxic Cancer Cells.

Matthias Müller1, Sara Espinoza2, Thomas Jüstel2

  • 1Wellman Center for Photomedicine.

Radiation Research
|November 19, 2019
PubMed
Summary
This summary is machine-generated.

Novel UVC-emitting LuPO4:Pr3+ nanoparticles combined with X-rays overcome radiation resistance in hypoxic lung cancer cells. This oxygen-independent approach sensitizes resistant cells to normoxic treatment levels, improving therapeutic outcomes.

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.5K
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
07:07

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

3.5K

Related Experiment Videos

Last Updated: Jan 3, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.4K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.5K
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
07:07

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

3.5K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Radiation Oncology

Background:

  • Hypoxic tumor regions pose a significant challenge in radiation therapy due to inherent resistance.
  • Developing oxygen-independent treatment strategies is crucial for enhancing tumor treatment efficacy.

Purpose of the Study:

  • To investigate the potential of UVC-emitting LuPO4:Pr3+ nanoparticles (NPs) combined with X-rays to overcome radiation resistance in hypoxic cancer cells.
  • To evaluate the uptake, proliferation effects, and cytotoxicity of these NPs in A549 lung cancer cells.

Main Methods:

  • Inverted time-lapse microscopy and transmission electron microscopy (TEM) for NP uptake and cell proliferation analysis.
  • Colony formation assay to assess cytotoxicity under normoxic and hypoxic conditions.
  • Combined treatment of A549 lung cancer cells with X-rays and LuPO4:Pr3+ NPs.

Main Results:

  • Transmission electron microscopy confirmed NP uptake by A549 cells after 24 hours of incubation.
  • LuPO4:Pr3+ NPs alone induced a concentration-independent cell growth delay but no significant cytotoxicity.
  • The combined X-ray and NP treatment reduced hypoxic cells' radiation resistance by half, matching normoxic levels, and increased overall cytotoxicity.

Conclusions:

  • UVC-emitting LuPO4:Pr3+ NPs can be effectively internalized by lung cancer cells.
  • The combination of X-rays and LuPO4:Pr3+ NPs demonstrates a promising strategy to overcome tumor hypoxia-induced radioresistance.
  • This approach sensitizes hypoxic cancer cells to radiation, potentially improving treatment outcomes in lung cancer therapy.